6 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 17634958 | RNA COMBINATIONS AND COMPOSITIONS WITH DECREASED IMMUNOSTIMULATORY PROPERTIES | SHIN, DANA H | 1635 | Final Rejection | Feb 11, 2022 |
| 17576583 | ARTIFICIAL NUCLEIC ACID MOLECULES | LEITH, NANCY J | 1636 | Non-Final OA | Jan 14, 2022 |
| 17620047 | ROTAVIRUS MRNA VACCINE | GRABER, JAMES J | 1631 | Final Rejection | Dec 16, 2021 |
| 17429182 | CODING RNA ADMINISTERED INTO THE SUPRACHOROIDAL SPACE IN THE TREATMENT OF OPHTHALMIC DISEASES | FAY, ZOHREH ALEMZADEH | 1617 | Non-Final OA | Aug 06, 2021 |
| 17378954 | COMPOSITION FOR TREATING LUNG CANCER, PARTICULARLY OF NON-SMALL LUNG CANCERS (NSCLC) | WILSON, MICHAEL C | 1638 | Final Rejection | Jul 19, 2021 |
| 17045236 | NOVEL YELLOW FEVER NUCLEIC ACID MOLECULES FOR VACCINATION | VYAS, KEYUR ANILKUMAR | 1637 | Non-Final OA | Oct 05, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial